Related references
Note: Only part of the references are listed.Update on angiotensin AT2 receptors
Robert M. Carey
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
Jan M. Keppel Hesselink et al.
JOURNAL OF PAIN RESEARCH (2017)
Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo
Amanda K. Sampson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
Chirag Bavishi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
E. Bruce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Hypertension Renin-Angiotensin-Aldosterone System Alterations
Luuk te Riet et al.
CIRCULATION RESEARCH (2015)
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats
Mark Del Borgo et al.
CLINICAL SCIENCE (2015)
AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
Christine Koulis et al.
HYPERTENSION (2015)
A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
Luis C. Matavelli et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
Fibrosis - A Common Pathway to Organ Injury and Failure
Don C. Rockey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells
Abuzar Mahmood et al.
PLOS ONE (2015)
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli
Sadashiva S. Karnik et al.
PHARMACOLOGICAL REVIEWS (2015)
Effects of Cardiac Overexpression of the Angiotensin II Type 2 Receptor on Remodeling and Dysfunction in Mice Post-Myocardial Infarction
Jiang Xu et al.
HYPERTENSION (2014)
Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart
Dilyara Lauer et al.
HYPERTENSION (2014)
Therapeutic Targets in Heart Failure Refocusing on the Myocardial Interstitium
Erik B. Schelbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
Bryna S. Man Chow et al.
KIDNEY INTERNATIONAL (2014)
Saralasin and Sarile Are AT2 Receptor Agonists
Marie-Odile Guimond et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats
Giovanna Castoldi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Strategies for anti-fibrotic therapies
Joel Rosenbloom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle
Paula Painemal et al.
BIOFACTORS (2013)
Update on the Angiotensin AT2 Receptor
Claudia A. McCarthy et al.
CURRENT HYPERTENSION REPORTS (2013)
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Karl T. Weber et al.
NATURE REVIEWS CARDIOLOGY (2013)
Renin Inhibition and AT1R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling
Adam Whaley-Connell et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Harikrishna Makani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of reninangiotensinaldosterone system inhibitors involving 158 998 patients
Laura C. van Vark et al.
EUROPEAN HEART JOURNAL (2012)
Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury
Yanfei Qi et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Direct Angiotensin II Type 2 Receptor Stimulation in Nω-Nitro-L-Arginine-Methyl Ester-Induced Hypertension The Effect on Pulse Wave Velocity and Aortic Remodeling
Ludovit Paulis et al.
HYPERTENSION (2012)
Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
Koen Verdonk et al.
HYPERTENSION (2012)
Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
Asia Rehman et al.
HYPERTENSION (2012)
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
Sanja Bosnyak et al.
CLINICAL SCIENCE (2011)
Angiotensin AT2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
Luis C. Matavelli et al.
HYPERTENSION (2011)
A Single β-Amino Acid Substitution to Angiotensin II Confers AT2 Receptor Selectivity and Vascular Function
Emma S. Jones et al.
HYPERTENSION (2011)
cGMP Inhibits TGF-β Signaling by Sequestering Smad3 with Cytosolic β2-Tubulin in Pulmonary Artery Smooth Muscle Cells
Kaizheng Gong et al.
MOLECULAR ENDOCRINOLOGY (2011)
Of fads, fashion, surrogate endpoints and dual RAS blockade
Franz H. Messerli et al.
EUROPEAN HEART JOURNAL (2010)
Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
Franziska Rompe et al.
HYPERTENSION (2010)
Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage
Paolo Gelosa et al.
JOURNAL OF HYPERTENSION (2009)
Angiotensin II Type 2 Receptor Stimulation A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?
Elena Kaschina et al.
CIRCULATION (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
AT2 receptors: Functional relevance in cardiovascular disease
Emma S. Jones et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling
David C. Isbell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
ECM remodeling in hypertensive heart disease
Bradford C. Berk et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
Yoshitaka Nabeshima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease
Carlos M. Ferrario et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction
M Nakayama et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling
CM Bove et al.
HYPERTENSION (2004)
Increased collagen type I synthesis in patients with heart failure of hypertensive origin -: Relation to myocardial fibrosis
R Querejeta et al.
CIRCULATION (2004)
TGF-β-induced SMAD signaling and gene regulation:: consequences for extracellular matrix remodeling and wound healing
M Schiller et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2004)
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist
YQ Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer
BL Metcalfe et al.
HYPERTENSION (2004)
Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis
S Kurisu et al.
HYPERTENSION (2003)
Angiotensin AT(2) receptors: cardiovascular hope or hype?
RE Widdop et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction
ZQ Yang et al.
CIRCULATION (2002)
Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients
J Díez et al.
CIRCULATION (2002)
Myofibroblasts and mechano-regulation of connective tissue remodelling
JJ Tomasek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice
M Akishita et al.
CIRCULATION (2000)
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
CG Brilla et al.
CIRCULATION (2000)
Induction of cardiac fibrosis by transforming growth factor-beta(1)
PJ Lijnen et al.
MOLECULAR GENETICS AND METABOLISM (2000)
Share Paper
